{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:19:02Z","timestamp":1786979942678,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00280-021-04354-7","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T11:03:03Z","timestamp":1631530983000},"page":"1049-1053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pretherapeutic screening for Dihydropyrimidine deshydrogenase deficiency in measuring uracilemia in dialysis patients leads to a high rate of falsely positive results"],"prefix":"10.1007","volume":"88","author":[{"given":"Clotilde","family":"Gaible","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Narjoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Roueff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8486-3596","authenticated-orcid":false,"given":"Nicolas","family":"Pallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"issue":"5","key":"4354_CR1","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1053\/j.ajkd.2014.12.013","volume":"65","author":"AM Butler","year":"2015","unstructured":"Butler AM, Olshan AF, Kshirsagar AV et al (2015) Cancer incidence among US medicare ESRD patients receiving hemodialysis, 1996\u20132009. Am J Kidney Dis 65(5):763\u2013772. https:\/\/doi.org\/10.1053\/j.ajkd.2014.12.013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4354_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/annonc\/mds344","volume":"24","author":"N Janus","year":"2013","unstructured":"Janus N, Launay-Vacher V, Thyss A et al (2013) Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study. Ann Oncol 24(2):501\u2013507. https:\/\/doi.org\/10.1093\/annonc\/mds344","journal-title":"Ann Oncol"},{"issue":"15","key":"4354_CR3","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1200\/JCO.2003.10.065","volume":"21","author":"T Andre","year":"2003","unstructured":"Andre T, Colin P, Louvet C et al (2003) Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol 21(15):2896\u20132903. https:\/\/doi.org\/10.1200\/JCO.2003.10.065","journal-title":"J Clin Oncol"},{"issue":"7","key":"4354_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.ejca.2003.12.004","volume":"40","author":"ABP van Kuilenburg","year":"2004","unstructured":"van Kuilenburg ABP (2004) Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. Eur J Cancer 40(7):939\u2013950. https:\/\/doi.org\/10.1016\/j.ejca.2003.12.004","journal-title":"Eur J Cancer"},{"issue":"16","key":"4354_CR5","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/S1470-2045(15)00286-7","volume":"16","author":"D Meulendijks","year":"2015","unstructured":"Meulendijks D, Henricks LM, Sonke GS et al (2015) Clinical relevance of DPYD variants c.1679T>G, c.1236G>A\/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data. Lancet Oncol 16(16):1639\u20131650. https:\/\/doi.org\/10.1016\/S1470-2045(15)00286-7","journal-title":"Lancet Oncol"},{"issue":"2","key":"4354_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cpt.911","volume":"103","author":"U Amstutz","year":"2018","unstructured":"Amstutz U, Henricks LM, Offer SM et al (2018) Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update. Clin Pharmacol Ther 103(2):210\u2013216. https:\/\/doi.org\/10.1002\/cpt.911","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"4354_CR7","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/bjc.2017.94","volume":"116","author":"D Meulendijks","year":"2017","unstructured":"Meulendijks D, Henricks LM, Jacobs BAW et al (2017) Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicity. Br J Cancer 116(11):1415\u20131424. https:\/\/doi.org\/10.1038\/bjc.2017.94","journal-title":"Br J Cancer"},{"issue":"2","key":"4354_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.canlet.2006.09.006","volume":"249","author":"M Boisdron-Celle","year":"2007","unstructured":"Boisdron-Celle M, Remaud G, Traore S et al (2007) 5-Fluorouracil-related severe toxicity: a comparison of different methods for the pretherapeutic detection of dihydropyrimidine dehydrogenase deficiency. Cancer Lett 249(2):271\u2013282. https:\/\/doi.org\/10.1016\/j.canlet.2006.09.006","journal-title":"Cancer Lett"},{"issue":"13","key":"4354_CR9","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2217\/pgs.14.126","volume":"15","author":"J Sistonen","year":"2014","unstructured":"Sistonen J, B\u00fcchel B, Froehlich TK et al (2014) Predicting 5-fluorouracil toxicity: DPD genotype and 5,6-dihydrouracil:uracil ratio. Pharmacogenomics 15(13):1653\u20131666. https:\/\/doi.org\/10.2217\/pgs.14.126","journal-title":"Pharmacogenomics"},{"issue":"1","key":"4354_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/bcp.12790","volume":"81","author":"M Launay","year":"2016","unstructured":"Launay M, Dahan L, Duval M et al (2016) Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase-driven adaptive dosing of 5-FU in patients with digestive cancer. Br J Clin Pharmacol 81(1):124\u2013130. https:\/\/doi.org\/10.1111\/bcp.12790","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"4354_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bulcan.2018.02.001","volume":"105","author":"M-A Loriot","year":"2018","unstructured":"Loriot M-A, Ciccolini J, Thomas F et al (2018) Dihydropyrimidine d\u00e9hydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks. Bull Cancer 105(4):397\u2013407. https:\/\/doi.org\/10.1016\/j.bulcan.2018.02.001","journal-title":"Bull Cancer"},{"issue":"9","key":"4354_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s00228-014-1709-7","volume":"70","author":"KJ Barnes","year":"2014","unstructured":"Barnes KJ, Rowland A, Polasek TM, Miners JO (2014) Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins. Eur J Clin Pharmacol 70(9):1097\u20131106. https:\/\/doi.org\/10.1007\/s00228-014-1709-7","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"4354_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000167","volume":"2","author":"P Pedrazzoli","year":"2017","unstructured":"Pedrazzoli P, Silvestris N, Santoro A et al (2017) Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Societ\u00e0 Italiana di Nefrologia (SIN). ESMO Open 2(3):e000167. https:\/\/doi.org\/10.1136\/esmoopen-2017-000167","journal-title":"ESMO Open"},{"issue":"7","key":"4354_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1093\/annonc\/mdp598","volume":"21","author":"N Janus","year":"2010","unstructured":"Janus N, Thariat J, Boulanger H, Deray G, Launay-Vacher V (2010) Proposal for dosage adjustment and timing of chemotherapy in hemodialyzed patients. Ann Oncol 21(7):1395\u20131403. https:\/\/doi.org\/10.1093\/annonc\/mdp598","journal-title":"Ann Oncol"},{"issue":"2","key":"4354_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2017-000301","volume":"3","author":"T Funakoshi","year":"2018","unstructured":"Funakoshi T, Horimatsu T, Nakamura M et al (2018) Chemotherapy in cancer patients undergoing haemodialysis: a nationwide study in Japan. ESMO Open 3(2):e000301. https:\/\/doi.org\/10.1136\/esmoopen-2017-000301","journal-title":"ESMO Open"},{"issue":"5","key":"4354_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00280-020-04158-1","volume":"86","author":"Y Ozaki","year":"2020","unstructured":"Ozaki Y, Imamaki H, Ikeda A et al (2020) Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses. Cancer Chemother Pharmacol 86(5):693\u2013699. https:\/\/doi.org\/10.1007\/s00280-020-04158-1","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"4354_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41416-020-0962-z","volume":"123","author":"N Pallet","year":"2020","unstructured":"Pallet N, Hamdane S, Garinet S et al (2020) A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency. Br J Cancer 123(5):811\u2013818. https:\/\/doi.org\/10.1038\/s41416-020-0962-z","journal-title":"Br J Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-021-04354-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-021-04354-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T17:03:33Z","timestamp":1634922213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-021-04354-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4354"],"URL":"https:\/\/doi.org\/10.1007\/s00280-021-04354-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"20 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}